Millipore Sigma Vibrant Logo
Attenzione: Ci siamo trasferiti. Non è più possibile acquistare i prodotti Merck Millipore nel sito MerckMillipore.comPer saperne di più

70550 T7Select®10-3 Cloning Kit

70550
Purchase on Sigma-Aldrich

Panoramica

Replacement Information

Products

Numero di catalogoConfezionamento Qtà/conf
70550-3 Bottiglia di vetro 1 kit
Description
OverviewNovagen's T7Select® Phage Display System is a novel phage display system that takes advantage of the properties of bacteriophage T7. This system is easy to use and has the capacity to display peptides up to about 50 amino acids in size in high copy number (415 per phage), and peptides or proteins up to about 1200 amino acids in low copy number (0.1-1 per phage) or mid-copy number (5-15 per phage). Phage assembly takes place in the E. coli cytoplasm and mature phage are released by cell lysis. Unlike the filamentous systems, peptides or proteins displayed on the surface of T7 do not need to be capable of secretion through the cell membrane, a necessary step in filamentous phage assembly.

T7 has additional properties that make it an attractive display vector. It is very easy to grow and replicates more rapidly than either bacteriophage l or filamentous phage. Plaques form within 3h at 37°C and cultures lyse 1-2 h after infection, decreasing the time needed to perform the multiple rounds of growth usually required for selection. The T7 phage particle is extremely robust, and is stable to harsh conditions that inactivate other phage. This stability expands the variety of agents that can be used in biopanning selection procedures, which require that the phage remain infective. T7 is an excellent general cloning vector. Purified DNA is easy to obtain in large amounts, a high-efficiency in vitro packaging system has been demonstrated (2), and the DNA is completely sequenced (39,937 bp), so restriction or DNA sequence analysis of clones is quite straightforward.

The T7Select Phage Display System uses the T7 capsid protein to display peptides or proteins on the surface of the phage. The capsid protein is normally made in two forms, 10A (344 aa) and 10B (397 aa). 10B is produced by a translational frameshift at amino acid 341 of 10A, and normally makes up about 10% of the capsid protein. However, functional capsids can be composed entirely of either 10A or 10B, or of various ratios of the proteins. This finding provided the initial suggestion that the T7 capsid shell could accommodate variation, and that the region of the capsid protein unique to 10B might be on the surface of the phage and could be used for phage display.

There are 3 basic types of T7Select phage display vectors: the T7Select415 vector for high-copy number display of peptides, the T7Select10 vector for mid-copy number display of peptides or larger proteins, and the T7Select1 vectors for low-copy number display of peptides or larger proteins. In all of the vectors, coding sequences for the peptides or proteins to be displayed are cloned within a series of multiple cloning sites following aa 348 of the 10B protein. The natural translational frameshift site within the capsid gene has been removed, so only a single form of capsid protein is made from these vectors.


The T7Select System is sold for research use only. Any commercial use of this Product, including drug discovery or development of commercial products, requires a commercial license from EMD Millipore Corporation. Commercial use shall include but not be limited to (1) use of the Product or its components in manufacturing; (2) use of the Product or its components to provide a service, information, or data to others in exchange for consideration; (3) use of the Product or its components (or any derivatives thereof) for therapeutic, diagnostic or prophylactic purposes (including as part of a device, chip, assay or other product); or (4) resale of the Product or its components, whether or not such Product or its components are resold for use in research. Nothing contained herein shall be deemed to represent or warrant that additional third party rights are not required for use of this Product.
This product contains genetically modified organisms (GMO). Within the EU GMOs are regulated by Directives 2001/18/EC and 2009/41/EC of the European Parliament and of the Council and their national implementation in the member States respectively. This legislation obliges MilliporeSigma to request certain information about you and the establishment where the GMOs are being handled. Click here for Enduser Declaration (EUD) Form.
Catalogue Number70550
Brand Family Novagen®
References
Product Information
5 µgT7Select EcoR I/Hind III Vector Arms
0.2 pmolT7Select Control Insert
6T7 Packaging Extracts
1 µgT7Select Packaging Control DNA
0.2 mlBLT5403, BLT5615, and BL21 glycerol stock
500 pmolT7SelectUP primer
500 pmolT7SelectDOWN primer
Quality LevelMQ100
Applications
Biological Information
Physicochemical Information
Dimensions
Materials Information
Toxicological Information
Safety Information according to GHS
Safety Information
Product Usage Statements
Storage and Shipping Information
Ship Code Dry Ice Only
Toxicity Standard Handling
Storage ≤ -70°C
Avoid freeze/thaw Avoid freeze/thaw
Do not freeze Ok to freeze
Packaging Information
Transport Information
Supplemental Information
Specifications
Global Trade Item Number
Numero di catalogo GTIN
70550-3 04055977273700

Documentation

T7Select®10-3 Cloning Kit Certificati d'Analisi

TitoloNumero di lotto
70550

Citazioni

Titolo
  • Eun-Min Cho, et al. (2007) Phage display cDNA cloning and expression analysis of hydrophobins from the entomopathogenic fungus Beauveria (Cordyceps) bassiana. Microbiology 153, 3438-3447.
  • Lauren R.H. Krumpe, et al. (2006) T7 lytic phage-displayed peptide libraries exhibit less sequence bias than M13 filamentous phage-displayed peptide libraries. Proteomics 6, 4210-4222.
  • James E. Nowak, et al. (2006) Direct production and purification of T7 phage display cloned proteins selected and analyzed on microarrays. Bio/Techniques 40, 220-227.
  • Jan Pilch, et al. (2006) Peptides selected for binding to clotted plasma accumulate in tumor stroma and wounds. Proceedings of the National Academy of Sciences (USA) 103, 2800-2804.
  • Inge Roman, et al. (2006) Hunting interactomes of a membrane protein: obtaining the largest set of VDAC-interacting protein epitopes. Molecular and Cellular Proteomics 5, 1667-1680.
  • Jinguo Chen, et al. (2005) Tachyplesin activates the classic complement pathway to kill tumor cells. Cancer Research 65, 4614-4622.
  • Paul Whitley, et al. (2003) Identification of mammalian Vps24p as an effector of phosphatidylinositol 3,5-bisphosphate-dependent endosome compartmentalization. Journal of Biological Chemistry 278, 38786-38795.
  • Kimmo Porkka, et al. (2002) A fragment of the HMGN2 protein homes to the nuclei of tumor cells and tumor endothelial cells in vivo. Procedings of the National Academy of Science 99, 7444-7449.
  • Paul P. Sche, et al. (1999) Display cloning: functional identification of natural product receptors using cDNA-phage dispaly. Chemistry and Biology 6, 707-716.
  • Protocolli per l'uso

    Titolo
    TB178 T7Select® System Manual

    Mappa di un vettore

    Titolo
    TB243 T7Select® 10-3b Vector Map

    Sequenza del vettore

    Titolo
    T7Select® 10-3b Vector Sequence